Heart Disease Clinical Trials in Detroit

Showing 221-240 of 263 trials

Readiness for Behavior Change After a Heart Attack

NCT01596036

The purpose of this study is to test if an early appointment (within 10 days) when compared to a standard appointment (5 weeks) will affect attendance at the Cardiac Rehabilitation orientation and subsequent enrollment into cardiac rehabilitation.

Myocardial InfarctionStable AnginaCoronary Artery Disease

Henry Ford Health System150 participantsStarted Feb 2011

Detroit, Michigan, United States

COMPLETED< 1 mile

Physiological Response to Exercise: Sensor Evaluation at Specified Exertions

NCT01229137

Assessment of sensor parameter in patients with heart failure.

Heart Failure

Boston Scientific Corporation71 participantsStarted Jun 2011

Jonesboro, Arkansas, United States • Sacremento, California, United States • Danbury, Connecticut, United States +11 more locations

COMPLETEDPHASE4< 1 mile

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

NCT00863707

This study is intended to assess the safety and tolerance of regadenoson in subjects with renal impairment.

Kidney DiseasesCoronary Artery Disease

Astellas Pharma Inc511 participantsStarted Apr 2009

Anniston, Alabama, United States • Little Rock, Arkansas, United States • Bell Gardens, California, United States +38 more locations

Readiness for Behavior Change After a Heart Attack

Physiological Response to Exercise: Sensor Evaluation at Specified Exertions

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

Heart Disease Trials in Other Cities

Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI

TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)

The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices

The Epidemiology of Ventricular Assist Device-Related Infections

Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V

Effects of Chitin-Glucan on Oxidized Low-Density Lipoprotein (LDL)

Paracor Ventricular Support System (PVSS) for Patients With Heart Failure

Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac Stimulation

Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]

Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease

Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease

Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure

The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?

Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge

Other Conditions in Detroit